Irisin is a myokine involved in the browning of white adipose tissue and regulation of energy expenditure, glucose homeostasis and insulin sensitivity. Debated evidence exists on the metabolic role played by irisin in children with overweight or obesity, while few information exist in children with Prader Willi Syndrome (PWS), a condition genetically prone to obesity. Here we assessed serum irisin in relation to the metabolic profile and body composition in children and adolescents with and without PWS. In 25 PWS subjects [age 6.6-17.8y; body mass index standard deviation score (BMI SDS) 2.5 +/- 0.3] and 25 age, and BMI-matched controls (age 6.8-18.0y; BMI SDS, 2.8 +/- 0.1) we assessed irisin levels and metabolic profile inclusive of oral glucose tolerance test (OGTT), and body composition by dual-energy X-ray absorptiometry (DXA). In PWS, we recorded lower levels of fat-free mass (FFM) (p <0.05), fasting (p<0.0001) and 2h post-OGTT insulin (p<0.05) and lower insulin resistance as expressed by homeostatic model of insulin resistance (HOMA-IR) (p<0.0001). Irisin levels were significantly lower in PWS group than in controls with common obesity (p<0.05). In univariate correlation analysis, positive associations linked irisin to insulin OGTT(0) (p<0.05), insulin OGTT(120) (p<0.005), HOMA-IR (p<0.05) and fasting C-peptide (p<0.05). In stepwise multivariable regression analysis, irisin levels were independently predicted by insulin OGTT(120). These results suggest a link between irisin levels and insulin sensitivity in two divergent models of obesity.
Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism / S. Mai, D. Fintini, C. Mele, A. Convertino, S. Bocchini, G. Grugni, G. Aimaretti, R. Vietti, M. Scacchi, A. Crinò, P. Marzullo. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 13:(2022), pp. 918467.1-918467.8. [10.3389/fendo.2022.918467]
Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism
M. Scacchi;
2022
Abstract
Irisin is a myokine involved in the browning of white adipose tissue and regulation of energy expenditure, glucose homeostasis and insulin sensitivity. Debated evidence exists on the metabolic role played by irisin in children with overweight or obesity, while few information exist in children with Prader Willi Syndrome (PWS), a condition genetically prone to obesity. Here we assessed serum irisin in relation to the metabolic profile and body composition in children and adolescents with and without PWS. In 25 PWS subjects [age 6.6-17.8y; body mass index standard deviation score (BMI SDS) 2.5 +/- 0.3] and 25 age, and BMI-matched controls (age 6.8-18.0y; BMI SDS, 2.8 +/- 0.1) we assessed irisin levels and metabolic profile inclusive of oral glucose tolerance test (OGTT), and body composition by dual-energy X-ray absorptiometry (DXA). In PWS, we recorded lower levels of fat-free mass (FFM) (p <0.05), fasting (p<0.0001) and 2h post-OGTT insulin (p<0.05) and lower insulin resistance as expressed by homeostatic model of insulin resistance (HOMA-IR) (p<0.0001). Irisin levels were significantly lower in PWS group than in controls with common obesity (p<0.05). In univariate correlation analysis, positive associations linked irisin to insulin OGTT(0) (p<0.05), insulin OGTT(120) (p<0.005), HOMA-IR (p<0.05) and fasting C-peptide (p<0.05). In stepwise multivariable regression analysis, irisin levels were independently predicted by insulin OGTT(120). These results suggest a link between irisin levels and insulin sensitivity in two divergent models of obesity.File | Dimensione | Formato | |
---|---|---|---|
front endocrinol irisin in PWS children.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
502.45 kB
Formato
Adobe PDF
|
502.45 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.